Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.

  • Burning Rock Biotech's Consolidated Net Income rose 5443.72% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 million, marking a year-over-year increase of 7454.97%. This contributed to the annual value of -$45.9 million for FY2024, which is 4980.47% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Consolidated Net Income of -$2.3 million as of Q3 2025, which was up 5443.72% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Consolidated Net Income registered a high of -$1.3 million during Q2 2025, and its lowest value of -$41.2 million during Q1 2022.
  • Over the past 5 years, Burning Rock Biotech's median Consolidated Net Income value was -$23.9 million (recorded in 2023), while the average stood at -$21.6 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Consolidated Net Income tumbled by 20865.07% in 2021, and later soared by 9131.9% in 2025.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Consolidated Net Income stood at -$39.8 million in 2021, then grew by 22.56% to -$30.8 million in 2022, then grew by 26.79% to -$22.5 million in 2023, then skyrocketed by 57.06% to -$9.7 million in 2024, then skyrocketed by 76.29% to -$2.3 million in 2025.
  • Its Consolidated Net Income stands at -$2.3 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.8 million for Q1 2025.